Autopsy: The Premature Series A Attempt

The Company: B2B workflow automation for legal operations. $800K ARR, 120% NRR, growing 15% month-over-month.

The Outcome: 52 investor meetings over 4 months. Zero term sheets. Burned through half their remaining runway. Forced to raise an extension round at a flat valuation.

What Went Wrong:

The founder read the benchmarks: Series A typically happens at $1-2M ARR. She was at $800K and growing fast. Close enough, right?

Wrong. Here’s what the benchmarks don’t tell you:

• Benchmark ARR is a floor, not a target. The median Series A in legal tech in 2025 was $1.8M ARR. She was at the 15th percentile.
• Growth rate can’t substitute for scale. 15% MoM is strong, but VCs model forward: at that rate, she’d hit $1.5M ARR in 4 months. They told her to come back then.
• Pipeline doesn’t count. She had $600K in “committed” pipeline. VCs discounted this to zero — they’ve seen too many pipelines evaporate.

The cascading failures:

1. Burned top-tier firms first. She started with Tier 1 VCs and got quick passes. Those firms won’t re-engage for 12-18 months minimum.
2. Market signal spread. By meeting 50+, word got around. “Why has she talked to everyone?” became the question, not “why is she interesting?”
3. Team distraction. Four months of fundraising meant four months of the CEO doing half her job. Growth slowed to 10% MoM.

The Fix: She raised a $1.2M seed extension from existing investors and angels. Painful — the terms were worse than her original seed. But it bought 10 months of runway.

She’s now at $1.6M ARR and preparing to re-enter the Series A market. Different list, different positioning, different outcome expected.

What she’d do differently:

1. Get explicit feedback from 3-5 trusted VCs before launching broadly
2. Start with Tier 2/3 firms to calibrate, save Tier 1 for when the story was tight
3. Set a hard stop: if no term sheet in 8 weeks, pause and reassess